Pfizer | Sustainability Performance
Develops and markets pharmaceuticals and vaccines for various medical conditions.
1848
United States
10,001+ employees
Pharmaceuticals
$10B+ in revenue
$1B - 10B in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#9415
Overallⓘ#2144
in United Statesⓘ#228
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Carbon emissionsCarbon certificatesEnergy consumptionWaste ManagementWater ManagementGovernance
TargetsFinancial Data
Business performanceCapital & innovationAnalyst projections
Laggard
Critical
Aligned
Intensity
Greenhouse gas intensity Scope 1, 2 (tCO₂e /$M)
Greenhouse gas intensity (Scope 1, 2, 3)(tCO₂e /$M)
Energy consumption (direct) intensity (MWh /$M)
Water consumption intensity (m³ /$M)
Waste generation intensity (tonnes /$M)
Industry Benchmark
17.0
B/M 13.9
73.8
B/M 111.2
71.0
B/M 65.5
52.7
B/M 121.5
1.8
B/M 1.1
Powered by illuminem and GIST Impact
Controversy level
- Pfizer paid USD 2.3 billion to settle DOJ charges for off-label marketing of Bextra, the largest healthcare fraud settlement at the time.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
11+
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.